As a partner at De Gaulle Fleurance & Associés, Cécile Théard-Jallu specializes in the fields of innovative technologies, data protection / cybersecurity, commercial law, contracts and intellectual property. She has developed a strong experience acting for both international groups and SMEs, mostly in the fields of health, mobility and digital technologies.
She helps clients through the definition and implementation of their innovation strategies (regulations relating to healthcare products and activities, including telemedicine, HDS, 3D printing, connected objects, platforms, Big & Smart Data, social robots, artificial intelligence, blockchain, 5G, Smart Healthy Cities, or mobility around the patient pathway…).
She assists her clients in complex contractual transactions, including R&D and consortium, as well as technology transfer, licensing or clinical research projects or technological change, with or without public funding. She also has an extensive experience in advising clients on the structuring, design, negotiation and implementation of their commercial, IT and industrial contracts.
Since the beginning of her career, she has carried out numerous missions involving data protection, including the GDPR, the French Data Protection Act and French or European cybersecurity regulations, in various regulatory, contractual and auditing missions, on behalf of both industrial companies and service providers, in France and abroad (R&D, marketing or commercialization phase). She is a certified advisor to companies in the process of being certified as compliant with the GDPR by the Europrivacy ® consortium, the first certification scheme of its kind, financed by H2020 funds.
She represents De Gaulle Fleurance & Associés in the Cyber & Security Hub of the Systematic Cluster and has been appointed as an expert for France in the European project TEHDAS, aimed at building the regulation of the future European Health Data Area.
As a lawyer at Covington & Burling LLP in Washington DC, Cécile was seconded for about a year to one of the world’s leading medical equipment companies.
Vice-Chair of the “Health/Life Sciences” committee and member of the “Technology” committee of the International Bar Association (IBA), she has been listed for several years in the Best Lawyers ranking published in partnership with Les Echos, in the “Biotechnologies” and “Information Technologies” sections for France.
Very involved in the connected health ecosystem, in particular for medical devices players, she has written numerous articles in the specialized press and regularly hosts conferences in the sector.
Cécile Théard-Jallu was appointed as expert for France in the new European Project TEHDAS dedicated to the construction of the upcoming European Health Data Space. She is also certified to assist companies in their GDPR certification program within the Europrivacy scheme.
French - English
Cécile Thear-Jallu, Nataliia Ivanytska, “Data protection and privacy law”, Financier worldwide Ltd, août 2021
Cécile Théard-Jallu, Adèle Binnié, “Covid-19 vaccination passport and European Digital Green Certificate: a French and European law perspective on how fundamental rights are challenged”, The IBA Healthcare & Life Sciences Law Committee e-bulletin, 21 may 2021
Cécile Théard-Jallu, Vanessa Ruffa, “Vaccines against Covid-19: while they are now deployed around the globe who can be held liable in case of side effects?” PharmaNetwork, 19 avril 2021,
Cécile Théard-Jallu, Carlyne Sevestre, “France is launching an experimental phase on the use of therapeutic cannabis: an occasion to focus on the impact of CJEU’s confirmation of November 2020 on the free movement of CBD in the EU”, April 2021
Agnès Macaire, Cécile Théard-Jallu, Sophie Weill, “Véhicules connectés / autonomes, sources de valeur dans la smart city : point d’étape juridique et recommandations pratiques”, Dossier Mobilité Construction 21, 18 mars 2021
Cécile Théard-Jallu, Vanessa Ruffa, “Vaccine against Covid-19: What are the liabilities in the event of a side effect?”, PharmaNetwork Magazine, Octobre 2020
Cécile Théard-Jallu, co-écrit, “Mobilité, aménagement urbain et digital : quels enjeux juridiques pour les projets de Smart Healthy City à l’ère du Covid-19 ?”, Décryptage, De Gaulle Fleurance & Associés, septembre 2020
Cécile Théard-Jallu (co-auteur), Open health: how to re-use data in the context of the Covid-19 sanitary crisis in France, Healthcare and Life Sciences News, International Bar Association, septembre 2020
Cécile Théard-Jallu et Xavier Vuitton, “Chapter France”, The Life Science Law Review, 8ème édition, mai 2020
Cécile Théard-Jallu, “La dernière version du projet de loi de bioéthique pourrait-elle entraver les IA autonomes ?”, Mind Health, 4 février 2020
Cécile Théard-Jallu et Victor Fabre, “Blockchain: Hopes & Challenges”, PHARMAnetwork magazine, n°43, Octobre 2019
Cécile Théard-Jallu, “The GDPR: one year on”, Healthcare and Life Sciences News, International Bar Association, septembre 2019
Cécile Théard-Jallu, Guillaume Santiago, “DM “intelligents” : comment maîtriser les risques de responsabilités ?”, DeviceMed, n°5, septembre-octobre 2019
Cécile Théard-Jallu, Participation au panel « Valorisation des technologies émergentes en cancérologie » des Rencontres de la Cancérologie Française. Programme complet disponible ici, 27 novembre 2018
Cécile Théard-Jallu, “La blockchain au service de la santé ? L’exemple de la collecte du consentement du patient dans un essai clinique”, Revue Lamy, Droit des Affaires, “Blockchain: une révolution juridique ?”, septembre 2017
Cécile Théard-Jallu, Nina Gosse, “Unlocking the value of health data: implementation of a new ‘National Register of Health Data’ in France”, Healthcare and Life Sciences Committee News of the Legal Practice Division of the International Bar Association (Vol 2, No 1), septembre 2017
Cécile Théard-Jallu, Béatrice Fleuris, “The Digitalisation of the Maritime industry: Perspectives and key legal challenges for improved efficiency”, Geostrategic Maritime Review, Spring Summer edition 2017, l’Harmattan
Francine Le Péchon-Joubert, Cécile Théard-Jallu, “Block Exemption Regulation on technology transfer agreements: no global revolution but greater freedom of innovation to the benefit of licensees”, Intellectual Property and Entertainment Law, Newsletter of the International Bar Association Legal Practice Division, Volume 7 issue 1, septembre 2015